30 Day Survey
*
Please use the scale: 1=Much less, 2=Less, 3=The same amount, 4=More, 5=Much more, N/A=Not applicable to me
12345NA
Describe the pathophysiology of hypercholesterolemia, including risk assessment and preventive strategies for cardiovascular disease.
Examine clinical trial data for emerging PCSK9 inhibitors for the treatment of dyslipidemia presented at ESC 2016.
Integrate new data into individualized treatment plans to improve and maintain outcomes for patients with dyslipidemia.
*
Please use the scale: 1=Much less, 2=Less, 3=The same amount, 4=More, 5=Much more, N/A=Not applicable to me
12345NA
Utilize existing guidelines and recommendations when treating patients with dyslipidemia.
Develop personalized treatment plans incorporating PCSK9 inhibitors in order to improve outcomes in dyslipidemia patients.
Apply knowledge from clinical trial data in developing individualized treatment plans to maximize the number of patients meeting LDL-C goals.